Clinical and Radiographic Evaluation of Vital Pulpotomy Techniques in Primary Molars Using of Premixed Bioactive Bioceramic MTA (Neo-putty) as a Novel Pulpotomy Medication Versus Formocresol
Recruiting
N/A
Interventional Study
Vital
Pulpotomy
Techniques
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 4 – 9
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 44 (estimated)
- Sponsor
- October University for Modern Sciences and Arts · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Despite the benefit of formocresol, there are toxic effects allergic reactions and local soft and hard tissue necrosis have been reported when such formaldehyde compounds were used clinically, however, the adverse effect of the clinically used of this compound are not widely reported. It has been stated that it has a side effect on the permanent successor although it results as a successful techni…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Criteria The eligibility criteria were set according to the guidelines of AAPD, 2020. (4)
Inclusion Criteria:
1. 4 -9 years old
2. Primary molars with no spontaneous or provoked pain
3. Primary molars with at least two-thirds of the root length were still present.
4. Primary molars with no sign of…
Contacts